Home/Filings/4/0001695851-25-000004
4//SEC Filing

Fair Richard A. 4

Accession 0001695851-25-000004

CIK 0001672619other

Filed

Dec 11, 7:00 PM ET

Accepted

Dec 12, 6:31 PM ET

Size

5.6 KB

Accession

0001695851-25-000004

Insider Transaction Report

Form 4
Period: 2025-12-11
Fair Richard A.
DirectorPRESIDENT AND CEO
Transactions
  • Award

    Stock Option (right to buy)

    2025-12-11+875,000875,000 total
    Exercise: $18.77Exp: 2035-12-11Common Stock (875,000 underlying)
Footnotes (1)
  • [F1]1/4th of the shares subject to the option will vest on December 11, 2026 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Issuer

Enliven Therapeutics, Inc.

CIK 0001672619

Entity typeother

Related Parties

1
  • filerCIK 0001695851

Filing Metadata

Form type
4
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 6:31 PM ET
Size
5.6 KB